Prognostic mathematical models of the development of chronic non-viral liver diseases

Chronic non-viral liver diseases are one of the most pressing problems of modern internal medicine. Over the past two decades, there has been a steady increase in diseases of this group due to the widespread prevalence of major risk factors, such as obesity, diabetes mellitus, physical inactivity, alcohol abuse, irrational use of medications, etc. Since most of the patients represent the most able-bodied and active part of the population, this circumstance inevitably leads to significant financial, economic and humanitarian losses, which gives the problem acute social significance. The purpose of the study. To develop mathematical prognostic models of the development of the most common chronic non-viral liver pathology using the most important predictors of these diseases. Material and methods. The contingent included in the study consisted of 412 young and middle-aged men, 138 of them with non-alcoholic fatty liver disease, 50 with alcoholic liver disease, 157 with alcoholic-metabolic fatty liver disease and 67 people without pathology. The subjects were measured anthropometric indicators (height, body weight, calculation of body mass index, waist circumference), determination of the type of alcohol consumption according to the AUDIT questionnaire, the level of physical activity according to the IPAQ questionnaire. In the biochemical study of blood serum, the parameters of alanine and aspartate aminotransferase, total and direct bilirubin, alkaline phosphatase, gamma-glutamyltranspeptidase, glucose, insulin, and lipid spectrum were determined. The study of the qualitative and quantitative composition of the intestinal microbiome was carried out by sowing feces on nutrient media, followed by the determination of the species of microorganisms and the assessment of their quantitative content using microscopy. Ultrasound examination of the hepatobiliary zone included measuring the main sizes of the right and left lobes of the liver, as well as identifying the main signs of diffuse liver damage. To assess steatosis and liver fibrosis, a FibroScan 530 device was used with the functions of evaluating the parameter of controlled attenuation of ultrasound and transient elastography by controlled vibration. Statistical processing and analysis of the results obtained were performed using the StatTech 2.8.8 program. Results. Mathematical prognostic models have been developed to determine the probability of developing non-alcoholic fatty liver disease, alcoholic fatty liver disease and alcoholic-metabolic fatty liver disease. All the regression models obtained were statistically significant with sensitivity and specificity of more than 90%. AUROC diagnostic accuracy values exceeded 0.9 units, which characterizes the quality of diagnostic models as excellent. Conclusions. The use of mathematical prognostic models using publicly available data from objective and laboratory research methods allows optimizing the diagnosis of chronic non-viral liver diseases.

chronic non-viral liver diseases, non-alcoholic fatty liver disease, alcoholic liver disease, alcoholic-metabolic liver disease, diagnosis, prognostic mathematical model

1. Baryshnikova N.V., Belousova L. N. Alcoholic liver disease: features of diagnosis and treatment. Consilium Medicum. Gastroenterology. 2014; (2):16-18. (in Russ.)@@ Барышникова, Н. В. Алкогольная болезнь печени: особенности диагностики и лечения / Н. В. Барышникова, Л. Н. Белоусова // Consilium Medicum. Гастроэнтерология (Прил.). - 2014. - № 2. - С. 16-18.

2. Vinnitskaya E.V., Kiseleva A. V. Alcoholic liver disease in the practice of a therapist. Effektivnaya farmakoterapiya. Gastroenterologiya. 2014; 7:18-24. (in Russ.)@@ Винницкая, Е. В. Алкогольная болезнь печени в практике терапевта / Е. В. Винницкая, А. В. Киселева // Эффективная фармакотерапия. - 2014. - № 7. - С. 18-24.

3. Onishchenko G.G., Zhebrun A. B. Viral hepatitis in the Russian Federation 2010. Handbook. Saint-Petersburg: Pasteur Institute Rospotrebnadzor. 2010; 37 p. (in Russ.)@@ Вирусные гепатиты в РФ 2010: справочник / под ред. Г. Г. Онищенко, А. Б. Жебруна. - СПб.: НИИЭМ им. Пастера, 2010. - 37 с.

4. Serdyukov D. Yu., Gordienko A. V., Zhirkov I. I., et al. Metabolic status, ultrasound changes of the liver and vascular wall of arteries in men suffering from abdominal obesity. Bulletin of the Russian Military Medical Academy. 2020. 22 (1):31-35. (in Russ.) doi: 10.17816/brmma25963.@@ Сердюков, Д. Ю. Метаболический статус, ультразвуковые изменения печени и сосудистой стенки артерий у мужчин, страдающих абдоминальным ожирением / Д. Ю. Сердюков А. В. Гордиенко, И. И. Жирков и др. // Вестник Российской военно-медицинской академии. - 2020. - Т. 69, № 1. - С. 31-35. doi: 10.17816/brmma25963.

5. Serdyukov D. Yu., Gordienko A. V., Zhirkov I. I., et al. Criteria for the diagnosis of metabolically neutral obesity in military men. Voenno-meditsinskii Zhurnal. 2021. 342 (6):26-31. (in Russ.) doi: 10.52424/00269050_2021_342_6_26@@ Сердюков, Д. Ю. Критерии диагностики метаболически нейтрального ожирения у военнослужащих - мужчин / Д. Ю. Сердюков А. В. Гордиенко, И. И. Жирков и др. // Военно-медицинский журнал. - 2021. - Т. 342, № 6. - С. 26-31.

6. Younossi Z.M., Koenig A. B., Abdelatif D., et al. Global epidemiology of nonalcoholic fatty liver disease - meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016; 64 (1):73-84. doi: 10.1002/hep.28431

7. Ivashkin V.T., Drapkina O. M., Mayev I. V., et al. Prevalence of non-alcoholic fatty liver disease in patients of outpatient practice in the Russian Federation: results of the DIREG 2 study.Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2015. 25 (6):31-41. (in Russ.)@@ Ивашкин, В. Т. Распространенность неалкогольной жировой болезни печени у пациентов амбулаторно-поликлинической практики в Российской Федерации: результаты исследования DIREG 2 / В. Т. Ивашкин, О. М. Драпкина, И. В. Маев и др. // Росс. журн. гастроэнтерол., гепатол., колопроктол. - 2015. - № 6. - С. 31-41.

8. O’Shea R.S., Dasarathy S., McCullough A. J. Alcoholic liver disease. Hepatology. 2010;51(1):307-28. doi: 10.1002/hep.23258.

9. Zhirkov I. I., Gordienko A. V., Gulyaev N. I. Prevalence of non-viral chronic diffuse liver diseases among military personnel. Voenno-meditsinskii Zhurnal. 2020. 341 (2):82-83. (in Russ.) doi: 10.17816/RMMJ82312.@@ Жирков, И. И. Распространенность невирусных хронических диффузных заболеваний печени среди военнослужащих / И. И. Жирков, А. В. Гордиенко, Н. И. Гуляев // Военно-медицинский журнал. - 2020. - Т. 341, № 2. - С. 82-83. doi: 10.17816/RMMJ82312.

10. Zhirkov I.I., Gordienko A. V., Gulyaev N. I., et al. Chronic diffuse liver diseases of non-viral etiology in military personnel. Bulletin of the Russian Military Medical Academy. 2019. 68 (4): 72-76. (in Russ.)@@ Жирков, И. И. Хронические диффузные заболевания печени невирусной этиологии у военнослужащих / И. И. Жирков, А. В. Гордиенко, Н. И. Гуляев и др. // Вестник Российской военно-медицинской академии. - 2019. - № 4 (68). - С. 72-76.

11. Kravchuk. Yu. A. Kliniko-morfologicheskiye osobennosti steatogepatita alkogolnoy i metabolicheskoy etiologii. Diss. doct. med. nauk [Clinical and morphological features of steatohepatitis of alcoholic and metabolic etiology. Dr. med. sci. diss]. Saint-Petersburg, 2016. 286 p.@@ Кравчук, Ю. А. Клинико-морфологические особенности стеатогепатита алкогольной и метаболической этиологии: дис. … д-ра. мед. наук: 14.01.04 / Кравчук Юрий Алексеевич; Военно-медицинская академия. - С.- Петербург, 2016. - 286 c.

12. Pavlov Ch.S., Zolotarevsky V. B., Ivashkin V. T. Biopsy and morphological examination in the diagnosis of chronic liver diseases of various etiologies.Russian Journal of Gastroenterology, Hepatology and Coloproctology. 2007. 19 (1):90-94. (in Russ.)@@ Павлов, Ч. С. Биопсия и морфологическое исследование в диагностике хронических заболеваний печени различной этиологии / Ч. С. Павлов, В. Б. Золотаревский, В. Т. Ивашкин // Росс. журн. гастроэнтерол., гепатол., колопроктол. - 2007. - Т. 19, № 1. - С. 90-94.

13. Bedogni G., Bellentani S., Miglioli L.б et al. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterology. 2006; 33 (6):33. doi: 10.1186/1471-230X-6-33.

14. Bedossa P. Consortium FLIP. Utility and appropriateness for the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic liver disease. Hepatology. 2014; 60 (2):565-575. doi: 10.1002/hep.27173.

15. Zhirkov I. I. Gordienko A. V., Serdyukov D. Yu., et al. Key moments of etiopathogenesis of nonalcoholic fatty liver disease. Bulletin of the Russian Military Medical Academy. 2019; 66 (2):219-222. (in Russ.) doi: 10.17816/brmma25948.@@ Жирков, И. И. Ключевые моменты этиопатогенеза неалкогольной жировой болезни печени / И. И. Жирков, А. В. Гордиенко, Д. Ю. Сердюков и др. // Вестник Российской военно-медицинской академии. - 2019. - Т. 66, № 2. - С. 219-222. doi: 10.17816/brmma25948.

16. Babor T.F., de la Fuente J. R., Saunders J. B., et al. AUDIT. The Alcohol Use Disorders Identification Test: Guidelines for Use in Primary Health Care. Geneva: World Health Organization, 1992. - 30 p.

17. IPAQ Core Group. Guidelines for data processing and analysis of IPAQ - short and long forms. Available at: https://sites.google.com/site/theipaq (Access 05.05.2022.)